University
Health Sciences
Girolamo Pelaia works at “Magna Graecia” University of Catanzaro, Italy, where he is Full Professor of Pulmonary Medicine, Director of the Postdoctoral Specialization School of Respiratory Diseases, and Head of the Respiratory Disease Unit. Moreover, he currently holds the position of Chest Global Governor for Italy. He was born on 15 August 1960 in Catanzaro, Italy. In 1985 he received a degree in Medicine and Surgery, with distinction (“summa cum laude”), from the University of Reggio Calabria, Italy, and in 1989 he graduated with distinction (“summa cum laude”) as a Specialist in Respiratory Diseases at the University of Naples “Federico II”, Italy. He subsequently worked from 1990 to 1992 as a Postdoctoral Fellow at Georgetown University School of Medicine, Washington, D.C., USA. The clinical and research activities of Professor Pelaia primarily deal with the pathophysiology and treatment of asthma and chronic obstructive pulmonary disease (COPD). In particular, he is interested in the cellular and molecular mechanisms underlying the therapeutic effects of inhaled corticosteroids, long-acting bronchodilators, and anti-asthma biologic drugs. He has authored or co-authored more than 130 original articles and reviews published in international peer-reviewed journals, as well as several book chapters.

Moderator of 7 Sessions

Session Type
Parallel Session
Date
06/27/2022
Session Time
10:00 AM - 10:30 AM
Room
Hall A
Session Description
Description:

Management of mild asthma has been for a long time unsatisfactory and not tested in clinical trials. The use (overuse) of SABA in patients "treated as" mild asthmatics has become of concern, and the association with severe adverse events has become clear. Adherence to regular ICS treatment is a major issue in this population. The rationale and efficacy of the “as needed ICS” will be discussed in this session.

Learning Objectives:

• Review concerns associated with the use of rescue SABA in the absence of maintenance treatment.

• Discuss merits of as-needed ICS treatment strategies in mild asthma.

Session Type
Case Based Discussion
Date
06/28/2022
Session Time
08:00 AM - 09:00 AM
Room
Hall C
Session Type
Parallel Session
Date
06/28/2022
Session Time
10:35 AM - 12:15 PM
Room
Hall D
Session Description
Description:

Italians have contributed significantly to the advancement of medicine in general and respiratory diseases in particular. The role of Italians of different migratory generations have enrichened the landscape of respiratory diseases in the United States. In particular, the personal experience and academic contribution of three current clinician-scientists of Italian origin attest to the constructive role played by this ethnic group in the context of the diverse society in which we live.

Learning Objectives:

• Provide an overview of the contribution of Italians to medicine in general and respiratory medicine in particular.

• Provide a first-hand experience of three clinical-scientists of Italian origins in the respiratory medicine landscape in the United States.

Session Type
Parallel Session
Date
06/28/2022
Session Time
02:55 PM - 03:25 PM
Room
Hall A
Session Description
Description:

During this session we will review and discuss the clinical implications of recently published practice changing research..

Learning Objectives:

• Describe recently published clinical research likely to impact the detection, diagnosis, staging, or treatment of lung cancer.

• Discuss the clinical implications of the literature reviewed.

Session Type
Case Based Discussion
Date
06/29/2022
Session Time
08:00 AM - 09:00 AM
Room
Hall C
Session Type
Parallel Session
Date
06/29/2022
Session Time
11:10 AM - 11:40 AM
Room
Hall C
Session Description

Description:

The management of common and less common pulmonary and critical care disorders may require modification when caring for the pregnant patient. This session will review some of these topics.

Learning Objectives:

• Review the normal respiratory and cardiovascular physiology of pregnancy.

• Review the management of asthma, venous thromboembolism, and tuberculosis in pregnancy.

• Review the causes and management of acute respiratory failure in pregnancy.

Session Type
Parallel Session
Date
06/29/2022
Session Time
01:15 PM - 01:30 PM
Room
Hall A

Presenter of 2 Presentations

New Therapies in Severe Asthma

Session Type
Parallel Session
Date
06/28/2022
Session Time
04:10 PM - 05:50 PM
Room
Hall A
Lecture Time
05:00 PM - 05:25 PM

Targeted Biologics of Severe Asthma

Session Type
Parallel Session
Date
06/27/2022
Session Time
02:20 PM - 03:25 PM
Room
Hall A
Lecture Time
02:20 PM - 02:42 PM